HER2/EGFR in Cancer Research
HER2/EGFR in Cancer Research is a topic indexed in ScholarIQ from OpenAlex.
What is known about HER2/EGFR in Cancer Research?
This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer. It explores the mechanisms of action, resistance, and combination therapies involving chemotherapy and monoclonal antibodies. The cluster also delves into the role of EGFR, neuregulin 1, and ADAM metalloproteinases in HER2 signaling and breast cancer progression.
How many works does HER2/EGFR in Cancer Research have?
HER2/EGFR in Cancer Research has 68,447 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does HER2/EGFR in Cancer Research have?
HER2/EGFR in Cancer Research has 1,349,437 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for HER2/EGFR in Cancer Research?
The OpenAlex for HER2/EGFR in Cancer Research is on the source record.